Establishing Medicare Coverage for Pharmacogenomic Consultations by Clinical Pharmacists

ACCP’s legislative strategy recognizes that health policy often evolves incrementally. Cures 2.0 legislation aimed at modernizing access and coverage to innovative therapies generated bipartisan support in the last Congress. Of importance, the bill included Section 408: Medicare Coverage for Pharmacogenomic Consultations, which would establish a program to cover pharmacogenomic (PGx) consultations delivered by qualified clinical pharmacists. ACCP has been collaborating with its partner organizations to advance this potentially impactful provision.

• Click here to send a letter to Congress calling for the reintroduction of legislative language that would cover PGx consultations by qualified clinical pharmacists.